Asia shares extend bull run, dollar crawls off lows
January 29, 2018Hung out to dry twice, Tennessee city stumped by Trump’s washer tariffs
January 29, 2018How Sanofi’s setback could lead to better dengue vaccines
at
CHICAGO (Reuters) – New dengue vaccines being developed by Takeda Pharmaceuticals Co Ltd and U.S. government scientists are poised to provide a safer alternative to Sanofi’s Dengvaxia, according to vaccine experts, because they already take into account some of the issues that sidelined the product last year.
Powered by WPeMatico
